QbD Based Development and Validation of RP-HPLC Method for Nintedanib Esylate: Application to Bioanalytical and Stability Study in Plasma-Reference-Cited by-同舟云学术

QbD Based Development and Validation of RP-HPLC Method for Nintedanib Esylate: Application to Bioanalytical and Stability Study in Plasma

Published:2021-05-04 Issue:3 Volume:11 Page:392-408
ISSN:2229-7928
Container-title:Analytical Chemistry Letters
language:en
Short-container-title:Analytical Chemistry Letters

Author:

Waghmare Santosh. A.¹,Sumithra M.¹

Affiliation:

1. Department of Pharmaceutical Chemistry and Analysis, School of Pharmaceutical Sciences, Vels Institute of Science, Technology & Advanced Studies, Chennai, India

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/22297928.2021.1930581

Reference24 articles.

1. Liquid chromatography-tandem mass spectrometric assay for therapeutic drug monitoring of the EGFR inhibitors afatinib, erlotinib and osimertinib, the ALK inhibitor crizotinib and the VEGFR inhibitor nintedanib in human plasma from non-small cell lung cancer patients

2. Nintedanib-cyclodextrin complex to improve bio-activity and intestinal permeability

3. Interplay of multiple interaction forces: Binding of tyrosine kinase inhibitor nintedanib with human serum albumin

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A stability indicating method development and validation of a rapid and sensitive RP-HPLC method for Nintedanib and its application in quantification of nanostructured lipid carriers;F1000Research;2024-06-10

2. A brief review on application of design of experiment for the analysis of pharmaceuticals using HPLC;Annales Pharmaceutiques Françaises;2023-12

3. Pretreatment and analysis techniques development of TKIs in biological samples for pharmacokinetic studies and therapeutic drug monitoring;Journal of Pharmaceutical Analysis;2023-11

4. A stability indicating method development and validation of a rapid and sensitive RP-HPLC method for Nintedanib and its application in quantification of nanostructured lipid carriers;F1000Research;2023-10-20

5. Development, stability‐indicating assessment, and evaluation of influential method conditions using a full factorial design for the determination of Nintedanib esylate‐related impurities;Journal of Separation Science;2023-04-12